03.03.2015 Views

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

Disease staging: CliniCal anD CoDeD Criteria - HCUP

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Clinical <strong>Criteria</strong> with Description, Diagnostic Findings and ICD-9-CM codes<br />

DXCat Number: CVS12<br />

MultiStage: No<br />

DXCat Label: Digoxin Toxicity Specificity: A<br />

Etiology: Toxicologic<br />

Stage Description Diagnostic findings ICD-9-CM Codes<br />

1.01 Digoxin toxicity Digoxin level ≥ 3.0 ng/ml [chemistry report]<br />

DX 9721, E8583, E9421;<br />

(DX 2752, 2765-2766, 2768-2769,<br />

29281, 36815, 36859, 37734,<br />

7804, 7830, 7840, 78701-78703,<br />

78900-78909, 9952-99529) + ( DX<br />

E8583, E9421);<br />

2.01 with unifocal PVCs Stage 1.01<br />

AND unifocal premature ventricular contractions [EKG report]<br />

2.02 with Mobitz type I heart block Stage 1.01-2.01<br />

AND Mobitz type I heart block [EKG report]<br />

2.03 with multifocal PVCs Stage 1.01-2.02<br />

AND multifocal premature ventricular contractions [EKG report]<br />

3.01 with Mobitz II or third degree heart block Stage 1.01-2.03<br />

AND Mobitz type II heart block or 2:1 heart block [EKG report or Holter report]<br />

OR third degree heart block [EKG report or Holter report]<br />

3.02 with ventricular tachycardia Stage 1.01-3.01<br />

AND ventricular tachycardia [EKG report or Holter report or CRT monitor report]<br />

3.03 with ventricular fibrillation or flutter or Stage 1.01-3.02<br />

shock<br />

AND ventricular fibrillation [EKG report or Holter report or CRT monitor report]<br />

OR ventricular flutter [EKG report or Holter report or CRT monitor report]<br />

OR shock:<br />

4.00 with death Stage 1.01-3.03<br />

AND death<br />

STAGE 1.01 + DX 42769;<br />

STAGE 1.01-2.01 + (DX 42613,<br />

4266);<br />

NO;<br />

STAGE 1.01-2.03 + (DX 4260,<br />

42612, 42689, 4269);<br />

STAGE 1.01-3.01 + DX 4271;<br />

STAGE 1.01-3.02 + (DX 42741-<br />

42742);<br />

STAGE 1.01-3.02 + (GROUP<br />

SHOCKC OR GROUP SHOCKN);<br />

NO;<br />

References:<br />

Linden CH, Lovejoy Jr. FH. Poisoning and drug overdosage. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo, DL, eds. Harrison’s<br />

Principles of Internal Medicine. 14th Ed. New York, NY: McGraw-Hill; 1998:2523-2544.<br />

Massie BM, Amidon TM. Heart failure. In: Tierney Jr LM, McPhee SJ Papadakis MA, eds. Current Medical Diagnosis & Treatment. Stamford, CT: Appleton & Lange; 1998:403-<br />

412.<br />

Sopher SM, Camm AJ. Atrial fibrillation: maintenance of sinus rhythm versus rate control. American Journal of Cardiology. 1996:77(3):24A-37A.<br />

Thursday, January 07, 2010 9:21:17 AM<br />

©2010 Thomson Reuters. All rights reserved.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!